Corrigendum to "Efficacy of continued vedolizumab therapy in patients with Crohn's disease who did not respond to vedolizumab induction therapy at week 6" [J Crohns Colitis 8S1 (2014) P497 S274-5]

Journal of Crohn's and Colitis

Volumn 8, Issue 10, 2014, Pages 1337-

  Sandborn, W J ^a   Feagan, B ^b   Reinisch, W ^c,d   Smyth, M ^e   Xu, J ^f   Parikh, A ^f   Fox, I ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d MCMASTER UNIVERSITY   (Canada)

^e Takeda Global Research and Development Centre Europe   (United Kingdom)

^f TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^g Takeda Pharmaceuticals International Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR;

EID: 85028097647     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.08.001     Document Type: Erratum

References (0)